ArticleJournal of Cancer2026
Single-cell Transcriptomics Uncovers the Tumor Microenvironment and Collagen-CD44 Axis in HIV Positive Cervical Squamous Cell Carcinoma.
Article in Journal of Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Human immunodeficiency virus (HIV) infection markedly increases the incidence and worsens clinical outcomes of cervical squamous cell carcinoma (CSCC). The single-cell landscape of the tumor microenvironment (TME) in HIV positive CSCC (HIV-CSCC) remains poorly defined, and its cellular and molecular differences from HIV negative CSCC are largely unclear. Methods: We performed single-cell RNA sequencing (scRNA-seq) on tumor tissues from three HIV-CSCC patients without preoperative chemoradiotherapy. Public scRNA-seq data of three HIV negative CSCC cases were integrated as controls. We systematically analyzed cellular composition, transcriptional profiles, metabolic characteristics and intercellular communication networks across groups. Results: Epithelial cells in HIV-CSCC exhibited aggravated malignant phenotypes and metabolic disorders. The C5 epithelial subcluster was strongly associated with poor patient survival. Tumor-infiltrating T cells displayed impaired cytotoxic function. Macrophages predominantly polarized into immunosuppressive M2-like phenotypes with attenuated phagocytosis and antigen presentation. Cancer-associated fibroblasts (CAFs) acted as the core regulatory hub in HIV-CSCC TME and mediated cell crosstalk mainly via the collagen-CD44 signaling axis. Upregulated CD44 was an independent prognostic factor for unfavorable survival in HIV positive patients. Conclusions: HIV-CSCC is characterized by a highly immunosuppressive TME and extensive stromal remodeling driven by activated CAFs. The collagen-CD44 pathway plays a key role in tumor progression. Our findings reveal the molecular mechanism of HIV-CSCC and identify CD44 as a promising therapeutic target for this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.